Featured
Guide
Why GU trials stall at screening, and the first three things to change
A walkthrough of where genitourinary studies lose eligible patients between identification and consent, and how to close each gap.
Read the guideNews & Insights
Perspectives on trial enrollment.
Practical writing on why studies stall and what actually moves accrual.
Article
Referral pathways that actually bring in patients
Case note
Cutting time to activation on a stalled oncology study
Perspective
Enrollment is a design problem, not a marketing one
Want these in your inbox?
We send new writing when it is worth your time, and never more than that.